CLPBY vs. SCHG
Compare and contrast key facts about Coloplast A (CLPBY) and Schwab U.S. Large-Cap Growth ETF (SCHG).
SCHG is a passively managed fund by Charles Schwab that tracks the performance of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. It was launched on Dec 11, 2009.
Performance
CLPBY vs. SCHG - Performance Comparison
Loading graphics...
CLPBY vs. SCHG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CLPBY Coloplast A | -19.18% | -18.64% | -3.34% | 1.79% | -32.87% | 17.70% | 26.11% | 36.47% | 19.05% | 19.16% |
SCHG Schwab U.S. Large-Cap Growth ETF | -10.59% | 17.50% | 34.95% | 50.10% | -31.80% | 28.11% | 39.14% | 36.02% | -1.36% | 28.05% |
Returns By Period
In the year-to-date period, CLPBY achieves a -19.18% return, which is significantly lower than SCHG's -10.59% return. Over the past 10 years, CLPBY has underperformed SCHG with an annualized return of 1.33%, while SCHG has yielded a comparatively higher 16.83% annualized return.
CLPBY
- 1D
- 2.69%
- 1M
- -10.89%
- YTD
- -19.18%
- 6M
- -16.94%
- 1Y
- -31.99%
- 3Y*
- -16.88%
- 5Y*
- -12.40%
- 10Y*
- 1.33%
SCHG
- 1D
- 3.67%
- 1M
- -5.12%
- YTD
- -10.59%
- 6M
- -8.51%
- 1Y
- 16.81%
- 3Y*
- 21.91%
- 5Y*
- 12.55%
- 10Y*
- 16.83%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CLPBY vs. SCHG — Risk / Return Rank
CLPBY
SCHG
CLPBY vs. SCHG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Coloplast A (CLPBY) and Schwab U.S. Large-Cap Growth ETF (SCHG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CLPBY | SCHG | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -1.23 | 0.75 | -1.98 |
Sortino ratioReturn per unit of downside risk | -1.67 | 1.23 | -2.90 |
Omega ratioGain probability vs. loss probability | 0.79 | 1.17 | -0.38 |
Calmar ratioReturn relative to maximum drawdown | -0.82 | 1.03 | -1.85 |
Martin ratioReturn relative to average drawdown | -1.62 | 3.54 | -5.16 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| CLPBY | SCHG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.23 | 0.75 | -1.98 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.45 | 0.57 | -1.02 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.05 | 0.79 | -0.73 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.07 | 0.79 | -0.72 |
Correlation
The correlation between CLPBY and SCHG is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
CLPBY vs. SCHG - Dividend Comparison
CLPBY's dividend yield for the trailing twelve months is around 5.16%, more than SCHG's 0.43% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLPBY Coloplast A | 5.16% | 4.17% | 2.91% | 2.66% | 2.41% | 1.49% | 1.91% | 1.75% | 1.58% | 1.55% | 1.64% | 1.25% |
SCHG Schwab U.S. Large-Cap Growth ETF | 0.43% | 0.36% | 0.39% | 0.46% | 0.55% | 0.42% | 0.52% | 0.82% | 1.27% | 1.01% | 1.04% | 1.22% |
Drawdowns
CLPBY vs. SCHG - Drawdown Comparison
The maximum CLPBY drawdown since its inception was -60.32%, which is greater than SCHG's maximum drawdown of -34.59%. Use the drawdown chart below to compare losses from any high point for CLPBY and SCHG.
Loading graphics...
Drawdown Indicators
| CLPBY | SCHG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -60.32% | -34.59% | -25.73% |
Max Drawdown (1Y)Largest decline over 1 year | -39.36% | -16.41% | -22.95% |
Max Drawdown (5Y)Largest decline over 5 years | -60.32% | -34.59% | -25.73% |
Max Drawdown (10Y)Largest decline over 10 years | -60.32% | -34.59% | -25.73% |
Current DrawdownCurrent decline from peak | -58.57% | -13.34% | -45.23% |
Average DrawdownAverage peak-to-trough decline | -18.52% | -5.22% | -13.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.88% | 4.78% | +15.10% |
Volatility
CLPBY vs. SCHG - Volatility Comparison
Coloplast A (CLPBY) has a higher volatility of 9.28% compared to Schwab U.S. Large-Cap Growth ETF (SCHG) at 6.67%. This indicates that CLPBY's price experiences larger fluctuations and is considered to be riskier than SCHG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| CLPBY | SCHG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.28% | 6.67% | +2.61% |
Volatility (6M)Calculated over the trailing 6-month period | 19.21% | 12.51% | +6.70% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.15% | 22.43% | +3.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.55% | 22.32% | +5.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.02% | 21.51% | +4.51% |